We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+8.2%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$82.1B
AUM Growth
+$7.21B
(+9.6%)
Cap. Flow
+$2.14B
Cap. Flow
% of AUM
2.6%
Top 10 Holdings %
Top 10 Hldgs %
34.14%
Holding
3,101
New
616
Increased
843
Reduced
896
Closed
659
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$700M |
| 2 |
Meta Platforms (Facebook)
META
|
+$651M |
| 3 |
Flutter Entertainment
FLUT
|
+$606M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$464M |
| 5 |
Accenture
ACN
|
+$402M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$495M |
| 2 |
Spotify
SPOT
|
+$377M |
| 3 |
Humana
HUM
|
+$350M |
| 4 |
Goldman Sachs
GS
|
+$324M |
| 5 |
Merck
MRK
|
+$307M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.11% |
| 2 | Consumer Discretionary | 14.61% |
| 3 | Healthcare | 12.89% |
| 4 | Industrials | 6.78% |
| 5 | Financials | 6.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Monte Rosa Therapeutics
GLUE
$1.91B
| $921K | ﹤0.01% |
+173,849
| New | +$877K |
|
1652
Amylyx Pharmaceuticals
AMLX
$2.17B
| $920K | ﹤0.01% |
+283,986
| New | +$638K |
|
1653
MDU Resources
MDU
$4.37B
| $918K | ﹤0.01% |
60,440
+13,250
| +28% | +$189K |
|
|
SII
1654
Sprott
SII
$2.7B
| $913K | ﹤0.01% |
21,090
-13,607
| -39% | -$576K |
|
|
ZYXI
1655
DELISTED
Zynex
ZYXI
| $911K | ﹤0.01% |
111,581
-98,284
| -47% | -$829K |
|
1656
Fidelity MSCI Health Care Index ETF
FHLC
$3.3B
| $907K | ﹤0.01% |
12,458
+6,079
| +95% | +$435K |
|
1657
Caledonia Mining Corp
CMCL
$365M
| $907K | ﹤0.01% |
60,624
+21,166
| +54% | +$256K |
|
1658
Autohome
ATHM
$2.46B
| $904K | ﹤0.01% |
27,719
-8,200
| -23% | -$214K |
|
1659
Lexicon Pharmaceuticals
LXRX
$991M
| $901K | ﹤0.01% |
574,150
-616,298
| -52% | -$1.1M |
|
1660
Graham Holdings Company
GHC
$5.08B
| $899K | ﹤0.01% |
+1,094
| New | +$830K |
|
|
TPH
1661
DELISTED
Tri Pointe Homes
TPH
| $896K | ﹤0.01% |
19,773
-74,165
| -79% | -$3.17M |
|
1662
Southside Bancshares
SBSI
$966M
| $892K | ﹤0.01% |
26,670
-13,498
| -34% | -$433K |
|
1663
BellRing Brands
BRBR
$1.52B
| $888K | ﹤0.01% |
+14,625
| New | +$811K |
|
1664
Carpenter Technology
CRS
$28.8B
| $887K | ﹤0.01% |
+5,557
| New | +$753K |
|
1665
WhiteHorse Finance
WHF
$140M
| $886K | ﹤0.01% |
76,534
+23,819
| +45% | +$283K |
|
1666
Rekor Systems
REKR
$86M
| $885K | ﹤0.01% |
749,733
-494,088
| -40% | -$727K |
|
|
RNWWW
1667
CALL
ReNew Energy Global PLC Warrant
RNWWW
$61.1K
| $881K | ﹤0.01% |
140,000
-52,271
| -27% | -$20.1K |
|
1668
GCM Grosvenor
GCMG
$756M
| $877K | ﹤0.01% |
+77,431
| New | +$832K |
|
|
TERN
1669
DELISTED
Terns Pharmaceuticals
TERN
| $874K | ﹤0.01% |
104,758
+78,773
| +303% | +$648K |
|
1670
ARK Blockchain & Fintech Innovation ETF
ARKF
$742M
| $871K | ﹤0.01% |
+29,193
| New | +$814K |
|
1671
Morgan Stanley Direct Lending Fund
MSDL
$1.3B
| $870K | ﹤0.01% |
+44,005
| New | +$912K |
|
1672
Intuit
INTU
$83.1B
| $869K | ﹤0.01% |
1,400
+847
| +153% | +$541K |
|
1673
First Citizens BancShares
FCNCA
$24.3B
| $869K | ﹤0.01% |
472
-1,296
| -73% | -$2.47M |
|
1674
Navient
NAVI
$809M
| $866K | ﹤0.01% |
55,557
-104,240
| -65% | -$1.6M |
|
1675
MaxCyte
MXCT
$109M
| $866K | ﹤0.01% |
222,594
-277,075
| -55% | -$1.17M |
|
Similar funds
Marshall Wace's Q3 2024 Portfolio in Review
As of Q3 2024, Marshall Wace held 3,101 positions worth $82.1B, up 9.6% from $74.9B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Marshall Wace's Q3 2024 filing shows 616 new, 843 increased, 896 reduced and 659 closed positions. Its largest new stake was Texas Instruments: 1,008,812 shares worth $208M. The largest sale was Costco, an estimated $495M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Marshall Wace's largest Q3 2024 buy was Texas Instruments: 1,008,812 shares worth $208M.
- Marshall Wace added most to Tesla in Q3 2024, an estimated $700M increase.
- Marshall Wace's biggest Q3 2024 reduction was Costco, cutting an estimated $495M.
- Marshall Wace fully exited Shopify in Q3 2024, selling an estimated $209M.
- Marshall Wace's ten largest holdings make up 34% of its $82.1B portfolio in Q3 2024.
- Marshall Wace opened 616 new positions and closed 659 in Q3 2024.
- Marshall Wace's portfolio value rose 9.6% quarter-over-quarter to $82.1B.
Based on Marshall Wace's 13F filing for Q3 2024, filed 14 Nov 2024.